Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
US-10865419-B2 · Dec 15, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/471 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 57 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 3 |
| 2019 | 34 |
| 2020 | 20 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
US-10822377-B2 · Nov 3, 2020 · US
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertensions, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
US-10806775-B2 · Oct 20, 2020 · US
Culture Method for Organoids
US-2020318063-A1 · Oct 8, 2020 · US
Two-dimensional polymeric structures and method for producing thereof
US-10758492-B2 · Sep 1, 2020 · US
Systems and methods for delivery of a therapeutic agent
US-10729897-B2 · Aug 4, 2020 · US
CD47 targeted therapies for the treatment of infectious disease
US-10723803-B2 · Jul 28, 2020 · US
1,2,4-Oxadiazole Derivatives as Immunomodulators
US-2020199086-A1 · Jun 25, 2020 · US
Antibacterial compositions, methods of making and use thereof
US-2020197483-A1 · Jun 25, 2020 · US
Mitrecin a polypeptide with antimicrobial activity
US-10688161-B2 · Jun 23, 2020 · US
Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
US-10676510-B2 · Jun 9, 2020 · US
Culture Method for Organoids
US-2020172861-A1 · Jun 4, 2020 · US
Compositions and methods for inhibiting bacterial growth
US-10653679-B2 · May 19, 2020 · US
Nucleic acid-cationic polymer compositions and methods of making and using the same
US-2020138977-A1 · May 7, 2020 · US
Modulation of Bacterial Quorum Sensing With Synthetic Ligands
US-2020115356-A1 · Apr 16, 2020 · US
Systems and methods for delivery of a therapeutic agent
US-10610675-B2 · Apr 7, 2020 · US
Compositions and methods for the removal of biofilms
US-10595530-B2 · Mar 24, 2020 · US
1,2,4-oxadiazole derivatives as immunomodulators
US-10590093-B2 · Mar 17, 2020 · US
Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients
US-10556932-B2 · Feb 11, 2020 · US
Substituted Urea Depsipeptide Analogs as Activators of the CLPP Endopeptidase
US-2020031872-A1 · Jan 30, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/471?
- CPC Y02A50/471 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/471 (Cross-Sectional Technologies)?
- Our database includes 57 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/471 growing?
- Publication counts under this code: 34 in 2019 vs 20 in 2020 (latest complete years).